Türkçe
Deutsch
The differences between prostate and testicular cancer are clearly distinguished in terms of the organ they originate from, age of occurrence, clinical course, and treatment approaches. While prostate cancer generally develops in older men, testicular cancer occurs more often in young adults and shows different biological behaviors.
Prostate cancer symptoms and risk factors are characterized by findings such as difficulty urinating, frequent urination, and elevated PSA. Family history, age, and hormonal effects play an important role. The disease often progresses slowly and can be detected at an early stage through screening.
Testicular cancer symptoms and the diagnostic process manifest with a painless mass in the testicle, swelling, and a feeling of fullness. Ultrasonography and tumor markers are used in diagnosis. Genetic predisposition and a history of undescended testis are among the important risk factors.
A comparison of prostate and testicular cancer treatment methods shows that surgery, radiotherapy, and chemotherapy options vary according to the disease. While active surveillance is possible in prostate cancer, testicular cancer requires rapid treatment and a high cure rate can be achieved with early intervention.
Do Prostate and Testicular Cancer Occur at the Same Ages?
Prostate and testicular cancer hold an important place among cancer types seen in men. However, they differ clearly from each other in terms of frequency of occurrence and affected age groups.
Prostate cancer is one of the most common cancer types in men. Its incidence increases significantly, especially in men over the age of 50. Worldwide, the majority of patients diagnosed with prostate cancer are aged 65 and over. A similar picture is seen in Turkey; prostate cancer is the second most common cancer type in men over the age of 60. Despite this high incidence, prostate cancer usually progresses slowly, which allows it to be treated successfully when diagnosed early.
Testicular cancer has a very different age profile. It is most commonly seen in young men between the ages of 15 and 35 and is one of the most common cancer types in this age group. Although it is a rare cancer compared to the general population, it creates a serious health problem because it appears at young ages. As age advances, the incidence of testicular cancer decreases; it is rarely encountered after the age of 40.
When evaluated in terms of frequency, prostate cancer is much more common than testicular cancer. However, the fact that testicular cancer is seen more frequently in young men makes it necessary to increase public awareness about this disease. Its occurrence at an early age may create deeper effects on an individual’s fertility and psychological health.
It is also known that both cancers are affected by factors such as family history, genetic predisposition, and lifestyle. While the most determining risk factor in prostate cancer is advanced age, testicular cancer threatens the younger age group more.
Which Is Riskier, Prostate Cancer or Testicular Cancer
Prostate and testicular cancer occur in different age groups and through different biological mechanisms. Therefore, the risk factors of both cancer types are also different. These differences play an important role in individuals planning their personal health management.
The most important risk factor for prostate cancer is age. After the age of 50, the risk increases significantly, and in men aged 65 and over, it reaches its peak. Apart from this, genetic predisposition is also a very effective factor. In people with a history of prostate cancer in first-degree relatives, especially father or brother, the risk doubles. Mutations in the BRCA1 and BRCA2 genes may also increase the likelihood of developing prostate cancer. Racial factors also draw attention; for example, men of African descent have a higher risk of prostate cancer and the disease progresses more aggressively. In addition, a fatty diet, obesity, and a sedentary lifestyle may also support the development of prostate cancer.
In terms of testicular cancer, age shows an inverse profile among risk factors. This cancer, which is more common in young adult men, peaks between the ages of 15 and 35. The most important risk factor is cryptorchidism, meaning the testicle has not descended into the scrotum. Even if this condition has been corrected surgically, it increases the risk of testicular cancer. Family history, especially a history of testicular cancer in a brother, may multiply the risk. In addition, in individuals with a personal history of testicular cancer, the likelihood of developing cancer in the other testicle increases. While it is more common in the white race, it is rare in black men. Testicular trauma or some hormonal disorders affecting sperm production are also among the risk factors, although with low probability.
For both cancer types, general risk factors such as exposure to environmental toxins, long-term contact with certain chemical substances, and smoking should also be considered. However, testicular cancer may often occur without an obvious risk factor.
Are the Symptoms of Prostate and Testicular Cancer the Same?
Since prostate and testicular cancers originate from different parts of the body and different cell types, their symptom profiles are also quite different. Recognizing these symptoms is vitally important for early diagnosis and effective treatment.
Because prostate cancer is generally a slowly progressing disease, it often does not cause symptoms in its early stages. This causes the disease to progress silently. Symptoms usually appear when the tumor begins to affect the prostate gland or surrounding structures. The most common symptoms include frequent urination, especially waking up at night to urinate, difficulty urinating, weak urine flow, a feeling of not being able to fully empty the bladder, and blood in the urine. In some cases, if the disease has spread to the bones, pain may be felt in the hips, back, or thighs. In advanced stages, weight loss and loss of appetite may also be seen.
Testicular cancer, on the other hand, is a disease that gives earlier symptoms and differs from prostate cancer in this respect. The most common symptom is a painless swelling or hardness in the testicle. Men usually notice a mass or shape change during self-examinations. Sometimes pain in the testicle, a feeling of heaviness, or fluid accumulation in the scrotum may also be seen. More rarely, if the testicular tumor has a hormone-secreting structure, hormonal changes such as breast enlargement (gynecomastia) may also occur. As the disease progresses, pain spreading to the lower back, abdomen, or chest area may also develop.
The common point to pay attention to in both cancer types is being aware of abnormal signals given by the body. Especially when changes in the urinary tract or an unusual condition in the testicular area are noticed, it is of great importance to consult a urologist without delay.
Is There a Difference in the Diagnosis of Prostate and Testicular Cancer?
The diagnostic processes of prostate and testicular cancers are shaped according to the difference in the tissues where the diseases begin. While early diagnosis is vitally important in both cancer types, diagnostic methods include both physical examination and laboratory and imaging techniques.
Prostate cancer is usually diagnosed in an asymptomatic period during routine check-ups. The first step in diagnosis is digital rectal examination (DRE). In this method, the doctor enters through the rectum with a gloved finger, checks the prostate gland, and evaluates whether there is irregularity, hardness, or swelling. After this, the PSA (prostate-specific antigen) blood test, which is the most common screening test, is performed. PSA is a protein produced by prostate cells, and when its level in the blood rises, the possibility of prostate cancer comes into question. However, an increase in PSA level may also occur due to other causes such as infection or benign prostate enlargement.
If there are suspicious findings in the PSA test or rectal examination, prostate biopsy is performed to make a definitive diagnosis. In this procedure, samples are taken from prostate tissue under ultrasound guidance and examined in the laboratory. In some cases, multiparametric prostate MRI is also used to obtain very sharp images.
Testicular cancer diagnosis usually begins with a mass or swelling noticed by the patient himself. In this case, the first test to be performed is testicular ultrasound. Ultrasound shows the internal structure of the testicle in detail and reveals the presence and size of the tumor. If a suspicious formation is detected, blood tests are performed. In testicular cancer, some tumor markers are quite helpful in diagnosis. The most commonly checked tumor markers include alpha-fetoprotein (AFP), beta-hCG, and LDH. Elevation of these markers provides clues about the type of tumor.
Biopsy is rarely performed in testicular cancer because in testicular tumors, biopsy may lead to the spread of cancer, so surgical removal of the testicle directly (orchiectomy) is preferred. After surgery, the removed tissue is examined pathologically and the diagnosis is confirmed.
Are Prostate and Testicular Cancer Treatments Similar?
Since prostate and testicular cancer are diseases that affect different age groups and have different biological behaviors, treatment approaches are also quite different. In both cancers, the stage of the disease, spread status, the patient’s age, and general health condition are the main determinants of the treatment plan.
Treatment options in prostate cancer are quite varied and are generally determined according to how advanced the disease is. In early-stage, low-risk prostate cancers, active surveillance or active follow-up may be preferred. In these methods, treatment is not applied to the patient immediately; the disease is monitored with tests at certain intervals. If signs that the cancer is progressing are seen, treatment is started.
In more advanced cases, surgical intervention may be the primary treatment option. In the surgical procedure known as radical prostatectomy, the entire prostate gland is removed from the body. This procedure can be performed with open, laparoscopic, or robotic methods. After surgery, side effects such as urinary incontinence or sexual dysfunction may develop.
Alternatively, radiotherapy is also frequently used. It can be applied with methods such as external beam therapy or brachytherapy (placing radioactive material directly into the prostate). In advanced stages, hormone therapy (androgen deprivation) is used to slow the growth of prostate cancer. This treatment suppresses tumor development by lowering testosterone levels. In metastatic cases, chemotherapy also comes into play.
Testicular cancer usually begins with surgery. As soon as the diagnosis is confirmed, the cancerous testicle is surgically removed (orchiectomy). After surgery, treatment continues according to the type and spread degree of the tumor. If the disease is limited only to the testicle, surgery is often sufficient. However, in some patients, retroperitoneal lymph node dissection (removal of lymph nodes behind the abdomen) may be required.
Testicular cancer is highly sensitive to chemotherapy. Especially in non-seminomas, treatment success with the BEP protocol (bleomycin, etoposide, cisplatin) is very high. In seminomas, both radiotherapy and chemotherapy are used effectively. Even in recurrent cases, the chance of treatment is high.
Is Recovery Difficult in Prostate Cancer?
The recovery process after prostate and testicular cancer differs depending on the treatment method applied, the stage of the disease, and the individual’s general health condition. For both cancer types, quality of life after treatment and the physical-psychological recovery process are as important as treatment success.
The most common problems after prostate cancer treatment are sexual dysfunctions and difficulty in urinary control. Especially after radical prostatectomy, side effects such as erectile dysfunction and urinary incontinence may be seen. This condition varies depending on the patient’s age, the surgeon’s experience, and the surgical technique applied. Similar problems may also occur after radiotherapy. However, over time, these side effects may partially or completely improve in most patients. Quality of life can be increased with physical therapy, pelvic muscle exercises (Kegel exercises), and some medication treatments.
In patients receiving hormone therapy, side effects such as hot flashes, weight gain, decreased bone density, and depression may be seen. Therefore, regular check-ups after treatment, bone health monitoring, and psychological support become important. Long-term follow-up is performed by monitoring PSA levels. Since recurrence may occur even years after treatment, this follow-up may continue for life.
The recovery process after testicular cancer treatment is generally faster. After orchiectomy (removal of the testicle), patients can return to their normal lives within a few weeks. Removal of one testicle does not affect hormone production or fertility in most men. However, sperm quality may decrease temporarily or permanently in patients receiving chemotherapy or radiotherapy. Therefore, the option of sperm freezing should definitely be evaluated before treatment.
Long-term side effects that may be seen after testicular cancer treatment include fatigue, appetite changes, loss of libido, and rarely negative effects on cardiovascular health. Therefore, directing patients to physical activity, developing healthy eating habits, and regular health check-ups are important.
Psychologically, after both cancer types, patients may experience anxiety, depression, and fear of developing cancer again. Therefore, psychosocial support should be an integral part of cancer treatment.
Which Spreads Faster, Prostate Cancer or Testicular Cancer?
The ways prostate and testicular cancers spread in the body, their metastatic tendencies, and the routes they follow play a major role in disease management. The metastatic tendencies of these cancers should be taken into account both at the diagnostic stage and in treatment planning.
Although prostate cancer grows slowly, it is a cancer type with the potential to spread to surrounding tissues and distant organs. Initially, it may usually spread to the tissues around the prostate, seminal vesicles, and the bladder. However, in advanced stages, it may metastasize to pelvic and retroperitoneal lymph nodes through lymph vessels. The most common distant metastasis site of prostate cancer is the bones. Especially axial skeletal regions such as the spine, hip bones, and ribs are frequently affected. Bone metastasis may cause serious symptoms such as back pain, bone fractures, and limitation of movement.
In addition to bone metastases, liver and lung metastases may also be seen in prostate cancer, but these occur in more advanced stages. When metastatic prostate cancer is diagnosed, hormone-suppressing treatments and chemotherapy are usually in the first line. Modern imaging methods, especially PSMA PET-CT, are quite effective in precisely determining the location of metastases.
Testicular cancer, on the other hand, is generally a tumor type that shows a more aggressive course but is much more sensitive to chemotherapy. The tendency of this cancer to spread is mostly through the lymphatic route. The most common metastasis area is the retroperitoneal lymph nodes, that is, the lymph nodes located behind the abdomen. Growth in this area may sometimes manifest as abdominal pain or a feeling of fullness. In more advanced stages, testicular cancer may also spread to organs such as the lungs, liver, and brain.
Seminoma-type testicular tumors generally spread later and more slowly, while non-seminomas tend to metastasize faster. Therefore, the type of testicular cancer directly affects the risk of spread. Whether the disease has metastasized also determines the treatment strategy. Even in spread testicular cancers, the chance of treatment is high because this tumor type is highly sensitive to chemotherapy.
Prof. Dr. Berkan Reşorlu, born in Ankara in 1979, completed his medical education at Ankara University between 1997 and 2003, and his specialization in urology at Ankara University Faculty of Medicine between 2003 and 2008. Academically, he received the title of associate professor in 2013 and professor in 2022.
He has conducted extensive case series studies in the field of endoscopic stone surgery, contributed surgeries performed on children under the age of 1 to the literature, and has gained international recognition with his stone scoring system and experimental surgical models.
